Subscribe To
SILO / Silo Pharma shares take off as anxiety and PTSD therapeutic candidate achieves milestone
SILO News
By Proactive Investors
August 8, 2023
Silo Pharma shares take off as anxiety and PTSD therapeutic candidate achieves milestone
Silo Pharma shares rose on Tuesday after the development stage biopharmaceutical company announced it has advanced the formulation development of its more_horizontal
By GlobeNewsWire
April 24, 2023
Silo Pharma to Present at Psychedelic Drug Development Conference
ENGLEWOOD CLIFFS, NJ, April 24, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutic more_horizontal
By PennyStocks
December 31, 2022
3 Essential Strategies for Penny Stocks Trading in 2023
Are you using these penny stocks trading strategies? The post 3 Essential Strategies for Penny Stocks Trading in 2023 appeared first on Penny Stocks t more_horizontal
By PennyStocks
December 30, 2022
Best Penny Stocks To Buy Before 2023? 4 To Watch Now
Penny stocks to watch this week with news before 2023. The post Best Penny Stocks To Buy Before 2023? more_horizontal
By GlobeNewsWire
October 7, 2021
Silo Pharma achieves milestone - Partner Zylo Therapeutics Receive DEA Approval to Advance Silos time released Ketamine technology
Englewood Cliffs NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the us more_horizontal
By GlobeNewsWire
October 7, 2021
Silo Pharma achieves milestone - Partner Zylo Therapeutics Receive DEA Approval to Advance Silos time released Ketamine technology
Englewood Cliffs NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the us more_horizontal
By GlobeNewsWire
October 7, 2021
Silo Pharma achieves milestone - Partner Zylo Therapeutics Receive DEA Approval to Advance Silos time released Ketamine technology
Englewood Cliffs NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the us more_horizontal